Skip to content
This is a text only leaflet, designed for the visually impaired. Please visit our electronic Medicines Compendium (eMC) website to view the original document which may contain images or tables.

You may be able to get this leaflet in large print, Braille or as an audio CD, call the RNIB Medicine Leaflet line on 0800 198 5000 for more information.

The product codes for this leaflet are: PL30306/0168, PL30306/0167, PL30306/0163, PL30306/0165, PL30306/0164, PL30306/0166

 

Olanzapine 2.5mg, 5mg, 7.5mg,10mg, 15mg, 20mg Film-coated Tablets

Company Details

Actavis UK Ltd


Whiddon ValleyBarnstapleDevonEX32 8NS
Telephone:
Fax:
Medical Information Direct Line:
Medical Information e-mail:medinfo@actavis.co.uk
[view all information leaflets from this company]

PATIENT INFORMATION LEAFLET

Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20mg

Film-coated Tablets

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
  • The full name of the product is Olanzapine 2.5mg, 5mg, 7.5mg, 10mg, 15mg and 20mg Film-coated Tablets but within the leaflet it will be referred to as Olanzapine tablets.

What is in this leaflet:

1 What Olanzapine tablets are and what they are used for
2 What you need to know before you take
3 How to take
4 Possible side effects
5 How to store
6 Contents of the pack and other information

Go to top of the page

1 What Olanzapine tablets are and what they are used for

Olanzapine tablets belong to a group of medicines called antipsychotics and is used to treat the following conditions:

Schizophrenia, a disease with symptoms such as hearing, seeing or sensing things which are not there, mistaken beliefs, unusual suspiciousness, and becoming withdrawn. People with this disease may also feel depressed, anxious or tense.

Moderate to severe manic episodes, a condition with symptoms of excitement or euphoria

Olanzapine tablets has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment.

Go to top of the page

2 What you need to know before you take

Do not take Olanzapine tablets if you

  • are allergic to olanzapine or any of the other ingredients of this medicine (listed in section 6). An allergic reaction may be recognised as a rash, itching, a swollen face, swollen lips or shortness of breath. If this has happened to you, tell your doctor.
  • have been previously diagnosed with eye problems such as certain kinds of glaucoma (increased pressure in the eye).

Warnings and precautions

Talk to your doctor or pharmacist before taking Olanzapine tablets

  • The use of Olanzapine tablets in elderly patients with dementia is not recommended as it may have serious side effects.
  • Medicines of this type may cause unusual movements mainly of the face or tongue. If this happens after you have been given Olanzapine tablets tell your doctor.
  • Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness. If this happens, contact your doctor at once.
  • Weight gain has been seen in patients taking Olanzapine tablets. You and your doctor should check your weight regularly.
  • High blood sugar and high levels of fat (triglycerides and cholesterol) have been seen in patients taking Olanzapine tablets. Your doctor should do blood tests to check blood sugar and certain fat levels before you start taking Olanzapine and regularly during treatement.
  • Tell the doctor if you or someone else in your family has a history of blood clots, as medicines like these have been associated with formation of blood clots.

If you suffer from any of the following illnesses tell your doctor as soon as possible:

  • Stroke or “mini” stroke (temporary symptoms of stroke)
  • Parkinson’s disease
  • Prostate problems
  • A blocked intestine (Paralytic ileus)
  • Liver or kidney disease
  • Blood disorders
  • Heart disease
  • Diabetes
  • Seizures

If you suffer from dementia, you or your carer/relative should tell your doctor if you have ever had a stroke or “mini”stroke.

As a routine precaution, if you are over 65 years your blood pressure may be monitored by your doctor.

Children and adolescents

Olanzapine tablets are not for patients who are under 18 years.

Other medicines and Olanzapine tablets

Only take other medicines while you are on Olanzapine tablets if your doctor tells you that you can. You might feel drowsy if Olanzapine tablets are taken in combination with antidepressants or medicines taken for anxiety or to help you sleep (tranquillisers).

Tell your doctor if you are taking, have recently taken or might take any other medicines.

In particular, tell your doctor if you are taking:

  • medicines for Parkinson’s disease.
  • carbamazepine (an anti-epileptic and mood stabiliser), fluvoxamine (an antidepressant) or ciprofloxacin (an antibiotic) - it may be necessary to change your Olanzapine tablets dose.

Olanzapine tablets with alcohol

Do not drink any alcohol if you have been given Olanzapine tablets as together with alcohol it may make you feel drowsy.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

The following symptoms may occur in newborn babies, of mothers that have used Olanzapine tablets in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. If your baby develops any of these symptoms you may need to contact your doctor.

You should not be given this medicine when breast-feeding, as small amounts of Olanzapine tablets can pass into breast milk.

Driving and using machines

There is a risk of feeling drowsy when you are given Olanzapine tablets. If this happens do not drive or operate any tools or machines. Tell your doctor.

Olanzapine tablets contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

Olanzapine tablets contains lecithin soya.

If you are allergic to peanut or soya, do not take this medicine.

Go to top of the page

3 How to take

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Your doctor will tell you how many Olanzapine tablets to take and how long you should continue to take them. The daily dose of Olanzapine is between 5 and 20 mg. Consult your doctor if your symptoms return but do not stop taking Olanzapine tablets unless your doctor tells you to.

You should take your Olanzapine tablets once a day following the advice of your doctor. Try to take your tablets at the same time each day. It does not matter whether you take them with or without food.

Olanzapine tablets are for oral use. You should swallow the Olanzapine tablets whole with water.

If you take more Olanzapine tablets than you should

Patients who have taken more Olanzapine than they should, have experienced the following symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness. Other symptoms may be: acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness, slowing of the breathing rate, aspiration, high blood pressure or low blood pressure, abnormal rhythms of the heart. Contact your doctor or hospital straight away if you experince any of the above symptoms. Show the doctor your pack of tablets.

If you forget to take Olanzapine tablets

Take your tablets as soon as you remember. Do not take a double dose to make up for a forgotten tablet.

If you stop taking Olanzapine tablets

Do not stop taking your tablets just because you feel better. It is important that you carry on taking Olanzapine tablets for as long as your doctor tells you.

If you suddenly stop taking Olanzapine tablets, symptoms such as sweating, unable to sleep, tremor, anxiety or nausea and vomiting might occur. Your doctor may suggest you to reduce the dose gradually before stopping treatment.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Go to top of the page

4 Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor immediately if you have:

  • unusual movement (a common side effect that may affect up to 1 in 10 people) mainly of the face or tongue;
  • blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people) especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing. If you notice any of these symptoms seek medical advice immediately;
  • a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness (the frequency of this side effect cannot be estimated from the available data).

Very common side effects (may affect more than 1 in 10 people) include

  • weight gain.
  • sleepiness and increases in levels of prolactin in the blood.

Common side effects (may affect up to 1 in 10 ) include

  • changes in the levels of some blood cells and circulating fats.
  • increases in the level of sugars in the blood and urine.
  • feeling more hungry.
  • dizziness.
  • restlessness.
  • tremor, muscle stiffness or spasm (including eye movements).
  • problems with speech.
  • constipation.
  • dry mouth.
  • rash.
  • loss of strength.
  • extreme tiredness.
  • water retention leading to swelling of the hands, ankles or feet; and sexual dysfunctions such as decreased libido in males and females or erectile dysfunction in males.
  • In the early stages of treatment, some people may feel dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting position. This will usually pass on its own but if it does not, tell your doctor.

Uncommon side effects(may affect up to 1 in100 people) include

  • slow heart rate.
  • sensitive to sunlight.
  • urinary incontinence, lack of ability to urinate.
  • hair loss.
  • absence or decrease in menstrual periods.
  • changes in breasts in males and females such as an abnormal production of breast milk or abnormal growth.

Other additional side effects for which a frequency cannot be estimated from the available data(not known) include

  • allergic reaction (e.g. swelling in the mouth and throat, itching, rash)
  • diabetes or the worsening of diabetes, occasionally associated with ketoacidosis (ketones in the blood and urine) or coma.
  • lowering of normal body temperature; seizures, usually associated with a history of seizures (epilepsy); spasms of the muscle of the eye causing rolling movement of the eye.
  • abnormal rhythms of the heart; sudden unexplained death.
  • inflammation of the pancreas causing severe stomach pain, fever and sickness.
  • liver disease appearing as yellowing of the skin and white parts of the eyes.
  • muscle disease presenting as unexplained aches and pains; prolonged and/or painful erection.

While taking olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature, redness of the skin and have trouble walking. Some fatal cases have been reported in this particular group of patients.

In patients with Parkinson’s disease, Olanzapine tablets may worsen the symptoms.

If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet.

Go to top of the page

5 How to store

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date, which is stated on the carton.

Blister packs:

Store in the original package in order to protect from light and moisture.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

Go to top of the page

6 Contents of the pack and other information

What Olanzapine tablets contain

  • The active substance is olanzapine. Each Olanzapine tablet contains either 2.5mg, 5mg, 7.5mg, 10mg, 15mg or 20mg of the active substance.
  • The other ingredients are (tablet core) lactose anhydrous, microcrystalline cellulose, crospovidone, magnesium stearate and (tablet film-coating) polyvinyl alcohol, titanium dioxide (E171), talc, lecithin soya (E322) and xanthan gum (E415). In addition the 15mg tablets contain indigo carmine (E132) and the 20mg tablets contain iron oxide red (E172).

What Olanzapine tablets look like and contents of the pack

Film-coated tablet 2.5mg: Round, biconvex, white film-coated tablet 6mm in diameter, marked with “O” on one side.

Film-coated tablet 5mg: Round, biconvex, white film-coated tablet 8mm in diameter, marked with “O1” on one side.

Film-coated tablet 7.5mg: Round, biconvex, white film-coated tablet 9mm in diameter, marked with “O2” on one side.

Film-coated tablet 10mg: Round, biconvex, white film-coated tablet 10mm in diameter, marked with “O3” on one side.

Film-coated tablet 15mg: Oval, biconvex, light blue film-coated tablet 7.35 x 13.35mm in diameter, marked with “O” on one side.

Film-coated tablet 20mg: Oval, biconvex, light pink film-coated tablet 7.5 x 14.5mm in diameter, marked with “O” on one side.

Pack sizes

2.5mg, 5mg, 10mg, 15mg, 20mg:

In blisters: 28 film-coated tablets.

7.5mg:

In blisters: 28 and 56 film-coated tablets.

Marketing Authorisation Holder

Actavis Group PTC ehf
Reykjavikurvegur 76-78
220 Hafnarfjordur
Iceland

Manufacturer

Actavis Ltd
B16 Bulebel Industrial Estate
Zejtun
ZTN 08
Malta
Go to top of the page

This leaflet was last revised in January 2013

If you would like a leaflet with larger text, please contact 01271 311257.

Actavis
Barnstaple
EX32 8NS
UK

AAAE1754


Text size normal Text size at 110% Text size at 120%

CHANGE FORMAT

 

USEFUL INFO

 

QUICK LINKS